PRAXAIR DISTRIBUTION MID-ATLANTIC LLC
PharmaPRAXAIR DISTRIBUTION MID-ATLANTIC LLC is a pharmaceutical company with 2 FDA-approved products.
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC's Key Drugs
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC's core commercial portfolio centers on MEDICAL AIR, USP, HELIUM, USP — its most strategically important drugs approved in the last 15 years.
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC's Recent FDA Approvals
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC's Therapeutic Areas
Disease areas where PRAXAIR DISTRIBUTION MID-ATLANTIC LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PRAXAIR DISTRIBUTION MID-ATLANTIC LLC Pipeline Snapshot
Active clinical trials for PRAXAIR DISTRIBUTION MID-ATLANTIC LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • MEDICAL AIR, USP leads revenue
- • 2 key drugs tracked
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2013-08-05
- Latest
- 2013-08-05
- Applications
- 2